Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiency

European Journal of Clinical Investigation

Volumn 29, Issue 1, 1999, Pages 17-26

  Ginzinger, D G ^a,g   Clee, S M ^a   Dallongeville, J ^b   Lewis, M E S ^a   Henderson, H E ^c   Bauje, E ^b   Rogers, Q R ^d   Jensen, D R ^e   Eckel, R H ^e   Dyer, R ^a   Innis, S ^a   Jones, B ^f   Fruchart, J C ^b   Hayden, M R ^a,h  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Centre for Molecular Medicine and Therapeutics   (Canada)

Author keywords

Cats; Lipoprotein lipase; Lipoproteins; Milk fatty acids; Oral fat load; Particle composition

Indexed keywords

CHOLESTEROL; FATTY ACID; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ANIMAL MODEL; ARTICLE; BODY FAT; BREAST MILK; CAT; DENSITY GRADIENT CENTRIFUGATION; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HYPERLIPOPROTEINEMIA TYPE 1; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANIMALS; BLOOD CHEMICAL ANALYSIS; CATS; CHOLESTEROL; DIETARY FATS; FATTY ACIDS; FEMALE; HETEROZYGOTE; HOMOZYGOTE; LACTATION; LIPIDS; LIPOPROTEIN LIPASE; LIPOPROTEINS; MALE; MILK; MUTATION; PARTICLE SIZE; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 0033003939     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00435.x     Document Type: Article

References (43)

1. 1 Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase from milk: the model enzyme in lipoprotein lipase research. In: Borensztajn J, editor. Lipoprotein lipase. Chicago: Everner Publishers; 1987. p. 15-77.
2. 2 Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989;320:1060-8.
3. 3 Glaser DS, Yost TJ, Eckel RH. Preheparin lipoprotein lipolytic activities: relationship to plasma lipoproteins and postheparin lipolytic activities. J Lipid Res 1992;33:209-14.
4. 4 Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Baudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease, 77th edn. New York: McGraw-Hill;.1995. p. 1913-32.
5. 5 Peterson J, Fujimoto WY, Brunzell JD. Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies. J Lipid Res 1992;33:1165-70.
6. 6 Pedersen ME, Cohen M, Schotz MC. Immunocytochemical localization of the functional fraction of lipoprotein lipase in the perfused heart. J Lipid Res 1983;24:512-7.
7. 7 Jukema JW, van Boven AJ, Groenemeijer B, et al. The Asp9Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis.REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. Circulation 1996;94:1913-8.
8. 8 Reymer PWA, Gagne E, Groenmeyer BE, et al. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet 1995;10:28-33.
9. 9 Bijvoet S, Gagne SE, Moorjani S, et al. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J Lipid Res 1996;37:640-50.
10. 10 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;326:801-9.
11. 11 Armstrong ML, Heistad DD. Animal models of atherosclerosis. Atherosclerosis 1990;85:15-23.
12. 12 Coleman T, Seip RL, Gimbel JM, Lee D, Maeda N, Semenkovich CS. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J Biol Chem 1995;270:12518-25.
13. 13 Weinstock PH, Bisgaier CL, Aalto-Setala K, et al. Severe hypertriglyceridemia, reduced high density lipoprotein and neonatal death in lipoprotein lipase knockout mice. J Clin Invest 1995;96:2555-68.
14. 14 Ginzinger DG, Lewis MES, Ma Y, et al. A mutation in the lipoprotein lipase gene is the molecular basis of chylomicronemia in a colony of domestic cats. J Clin Invest 1996;97:1257-66.
15. 15 Terpstra AHM, Sanchez-Muníz FJ, West CE, Woodward CJH. The density profile and cholesterol concentration of serum lipoproteins in domestic and laboratory animals. Comp Biochem Physiol 1982;71B:669-73.
16. 16 Demacker PN, van Heijst PJ, Hak-lemmers HL, Stalanhoef AF. A study of the lipid transport system in the cat, Felis domesticus. Atherosclerosis 1987;66:113-23.
17. 17 Chapman MJ. Animal lipoproteins: chemistry, structure, and comparative aspects. J Lipid Res 1980;21:789-853.
18. 18 Jones BR, Wallace A, Harding DRK, Hancock WS, Campbell CH. Occurrence of idiopathic familial hyperchylomicronemia in a cat. Vet Rec 1983;112:543-7.
19. 19 Traber MG, Kayden HJ, Rindler MJ. Polarized secretion of newly synthesized lipoproteins by CaCo-2 human intestinal cell line. J Lipid Res 1987;28:1350-63.
20. 20 Brousseau T, Clavey V, Bard JM, Fruchart JC. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins and lipoprotein particles. Clin Chem 1993;39:960-4.
21. 21 Sampson EJ, Demers LM, Kreig AF. Faster enzymatic determination of total serum cholesterol. Clin Chem 1974;21:1983-5.
22. 22 Allain CB, Poon LS, Chan FCS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
23. 23 Noble P. Electrophoresis separation of plasma lipoproteins in agarose gels. J Lipid Res 1968;9:693-700.
24. 24 Innis SM, Dyer R, Nelson CM. Evidence that palmitic acid is absorbed as sn-2 monoacylglycerol from human milk by breast fed infants. Lipids 1994;29:541-5.
25. 25 Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one step reaction. J Lipid Res 1987;27:114-20.
26. 26 Fischer RM, Mailly F, Peacock RE, et al. Interaction of the lipoprotein lipase asparagine 291 → serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res 1995;36:2104-12.
27. 27 Mailly F, Tugrul Y, Reymer PWA, et al. A common variant in the gene for lipoprotein lipase (Asp9→Asn): functional implications and prevalence in normal and hyperlipidemic subjects. J Lipid Res 1995;15:468-78.
28. 28 Gerdes C, Fisher RM, Nicaud V, et al. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European atherosclerosis research studies. Circulation 1997;96:733-40.
29. 29 Zambon A, Torres A, Bijvoet S, et al. Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolemia and lipoprotein lipase deficiency. Lancet 1993;341:1119-21.
30. 30 Bensadoun A, Berryrnan DE. Genetics and molecular biology of hepatic lipase. Curr Op Lipidol 1996;7:77-81.
31. 31 Watson TDG, Butterwick RF, McConnell M, Markwell PJ. Development of methods for analyzing plasma lipoprotein concentrations and associated enzyme activities and their use to measure the effects of pregnancy and lactation in cats. Am J Vet Res 1995;56:289-96.
32. 32 Inazu A, Brown ML, Hesler CB, et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990;323:1234-8.
33. 33 Tall AR. Plasma cholesterol ester transfer protein. J Lipid Res 1993;34:1255-74.
34. 34 Whitlock ME, Swenson TL, Ramakrishnan R, et al. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. J Clin Invest 1989;84:129-37.
35. 35 Abbey M, Calvert GD. Effects of blocking plasma lipid transfer protein activity in the rabbit. Biochim Biophys Acta 1989;1003:20-9.
36. 36 Eisenberg S, Gavish D, Oscary M, Fainaru M, Dekelbaum RJ. Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. J Clin Invest 1984;74:470-82.
37. 37 Sprecher DL, Knauer SL, Black DM, et al. Chylomicronretinyl palmitate clearance in type I hyperlipidemic families. J Clin Invest 1991;88:985-94.
38. 38 Miesenbock G, Holzl B, Foger B, et al. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest 1993;91:448-55.
39. 39 Steiner G, Myher JJ, Kuksis A. Milk and plasma lipid composition in a lactating patient with type I hyperlipoproteinemia. Am J Clin Nutr 1985;41:121-8.
40. 40 Scow RO, Chernick SS, Fleck TR. Lipoprotein lipase and uptake of triacylglycerol, cholesterol and phosphatidylcholine from chylomicrons by mammary and adipose tissue of lactating rats in vivo. Biochim Biophys Acta 1977;487:297-306.
41. 41 Scow RO, Blanchette-Mackie EJ, Smith LC. Transport of lipid across capillary endothelium. Fed Proc 1980;39:2610-7.
42. 42 Hachey DL, Silber GH, Wong WW, Garza C. Human lactation. II. Endogenous fatty acid synthesis by the mammary gland. Pediatr Res 1989;25:63-8.
43. 43 Thompson BJ, Smith S. Biosynthesis of fatty acids by lactating human breast epithelial cells: an evaluation of the contribution to the overall composition of human milk fat. Pediatr Res 1985;19:139-43.